Therapeutic composition with marked polydetoxifying properties, especially with regard to tobacco
AssigneeLaboratoire Theranol
InventorRobert Louis Prugnaud
Life of this patent
Estimating the term…
Abstract
A therapeutic detoxifying composition comprising a sympathoparalytic, vitamins from the groups B and C, and an organic salt of quinine. The composition may also contain an endogenous detoxifying substance. A preferred composition comprises Muramidase, nicotinamide, thiamine, ascorbic acid, pyridoxine, and a quinine salt having an organic anion, optionally with a sympathoparalytic sedative such as the dry extract of Crataegus root, all in specified proportions. The composition may be formulated with pharmaceutically acceptable carriers, and is markedly effective in detoxification therapy for solanaceous and ganglioplegic toxins such as nicotine and related toxic compounds.
Claims7
A therapeutic detoxifying composition comprising:
- a. extract of Crataegus
- b. a vitamin selected from the group consisting of vitamins PP, B, B.sub.1, B.sub.6 and C, and
- c. an organic salt of quinine selected from the group consisting of ascorbate, lactate, malate and pyruvate
- wherein (a), (b) and (c) are present in weight ratios of 4.5 to 450(a) to 7.5 to 750(b) and 1.5 to 150(c).
A therapeutic detoxifying composition comprising, in parts by weight:
- a. One part Muramidase;
- b. About one part pyridoxine;
- c. About five parts ascorbic acid;
- d. About one and one-half parts thiamine;
- e. About one part nicotinamide;
- f. About one part of an organic salt of quinine selected from the group consisting of ascorbate, lactate, malate, and pyruvate;
- g. About 3 parts dry extract of Crataegus root.
Dependencies are inferred from the claim text.